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Abstract: Various protocell models have been constructed de novo with the bottom-up 
approach. Here we describe a silica-based protocell composed of a nanoporous amorphous 
silica core encapsulated within a lipid bilayer built by self-assembly that provides for 
independent definition of cell interior and the surface membrane. In this review, we will first 
describe the essential features of this architecture and then summarize the current 
development of silica-based protocells at both micro- and nanoscale with diverse 
functionalities. As the structure of the silica is relatively static, silica-core protocells do not 
have the ability to change shape, but their interior structure provides a highly crowded and, 
in some cases, authentic scaffold upon which biomolecular components and systems could 
be reconstituted. In basic research, the larger protocells based on precise silica replicas of 
cells could be developed into geometrically realistic bioreactor platforms to enable cellular 
functions like coupled biochemical reactions, while in translational research smaller 
protocells based on mesoporous silica nanoparticles are being developed for targeted 
nanomedicine. Ultimately we see two different motivations for protocell research and 
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development: (1) to emulate life in order to understand it; and (2) to use biomimicry to 
engineer desired cellular interactions. 
Keywords: protocell; nanoporous silica; synthetic biology; supported lipid bilayer; FRET; 
nanomedicine; designs of life 
 
1. Introduction 
Synthetic biology is an emerging field with the overall goal to understand life processes using an 
engineering approach [1]. A powerful recent approach to synthetic biology has been the design, 
synthesis, and assembly of a complete genome and its transplantation into a recipient cell to create a new 
line of engineered cells [2]. While the genomes are known and can be built from scratch in this  
top-down approach, the myriad regulatory, metabolic, and signaling networks are not completely 
characterized. These top-down approaches have limitations for the understanding of fundamental 
molecular regulation, since the host organisms have a complex and incompletely defined molecular 
composition. Alternative biochemical methods using cell-free extracts or purified components are too 
simple to mimic cellular environments. Thus, understanding the detailed mechanism of the top-down 
engineered cell suffers from the existence of uncontrolled variables.  
A complementary approach for the engineering of living cells is the bottom-up synthesis of a cell 
from defined building blocks that may be as small as individual genes, proteins, and RNAs, utilizing a 
“protocell” platform built by directed self-assembly that provides for independent definition of the cell 
interior and the surface membrane [3,4]. We focus our review on a complementary bottom-up approach 
to engineer protocells using biomaterials or synthetic materials to mimic the living cells, with each 
component of the system precisely defined and controlled. This approach will allow us to work at the 
levels of both protein and gene regulation in a cell-like environment. This bottom-up approach is 
precisely complementary to the top-down approach. Although the composition of a bottom-up cell would 
be significantly simplified compared to a living cell, the bottom-up cell can be precisely controlled with 
adjustable variables. This single cell entity can serve as a multi-scale machine capable of perceiving 
external environmental cues and guiding the regulation of signaling transduction and gene/protein 
production inside the cells. A computational model can be established to provide the molecular insights 
by which the interactions between different components of the cell entity are programmed. We 
envisioned that the bottom-up and top-down approaches will ultimately converge on a minimal living 
cell, whose operation will be generally unraveled during the processes of constructing simple building 
blocks and bottom-up cell entities.  
This bottom-up approach is not entirely new as many other protocell designs have been used to 
understand life, such as liposomes, polymersomes, inorganic and hybrid protocells. Liposomes are the 
first and most widely used protocell design as the major components of the membranes of living cells 
are lipids [5]. In addition, the enclosed nominally spherical structure of liposomes provides basic 
compartmentalization and definition of interior and exterior. Two categories of liposomes have been 
made, the ones made of fatty acids or phospholipids, for different purposes. Fatty-acids based liposomes 
are postulated to be good models for prebiotic precursors to modern cells and may therefore shed light 
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on the origin of life [6,7]. As the main building blocks of modern cells’ membranes are phospholipids, 
liposomes made of synthetic or natural phospholipids have been the major protocell design for both 
reconstitution of membrane proteins, biochemical reactions and supramolecular assembly inside the 
liposomes [8–12]. Even though lipids are the most biomimetic choice for protocells, an emerging area 
of interest is discovering new membranes made of self-assembling polymers or proteins [13–15]. 
Consideration of these molecules not only greatly expands the library of molecules for membrane 
assembly, but also expands the repertoire of possible membrane properties, since other polymers exhibit 
some properties not possible with lipids. These polymersomes have been shown to be practical micro- 
or nano-reactors, accommodating even protein synthesis inside [16]. Other than organic materials for 
membranes, inorganic materials were also explored as a membrane material [17,18]. Silica nanoparticles 
coated by copolymers can electrostatically gate membrane permeability [19]. Importantly, hybrid protocells 
combining different compositions can be constructed. Liposomes with internal and fatty acid-coated 
coacervate microdroplets are examples of hybrid protocells [20,21]. Details on different protocell 
designs and their applications have been reviewed elsewhere [5,13,17]. The remainder of this review 
focuses on one type of hybrid protocell: nanoporous silica encapsulated within a supported lipid bilayer. 
2. Design, Synthesis and Advantages 
This class of protocells is comprised of rudimentary cell-like constructs formed by liposome fusion 
on a porous spherical silica particle [3] or a silica replica of a cell [22]. They have been recently shown 
in cell culture to be a useful tool for targeted drug delivery [4]. Compared to giant unilamellar vesicles 
(GUVs), which have been studied extensively as cell mimics [23–26], they offer several advantages:  
(1) As with natural cellular plasma membranes, the membrane bilayer of the protocell is supported on a 
porous, cytoskeleton-like scaffold. The membrane-scaffold interaction confers enhanced stability, lateral 
diffusivity and fusogenicity; (2) Proteins and other membrane-bound components can be more  
readily incorporated into the supported lipid bilayer (SLB) than into comparable GUV’s to achieve 
membrane-like functionality; (3) Protocells can be easily loaded with nucleic acids, proteins, and 
messenger molecules to mimic the cytoplasm by relatively simple immersion procedures. Association 
of biomolecular components with the high surface area of internal scaffold allows for high loading and 
mimicking of the crowded environment of living cells, known to impact intracellular reactions [27–29], 
while maintaining accessibility and diffusivity of ions and molecules; (4) The particle surface and internal 
scaffold charges as well as hydrophobicity can be independently varied via well-controlled silane coupling 
chemistry utilizing organosilane and bridged silsesquioxane silica precursors; (5) Through tailored 
electrostatic interactions, the SLB asymmetry and the orientation of transmembrane proteins can be 
controlled; (6) The “intracellular” pKa and the extent of hydrogen bonding and electrostatic interactions 
with biomolecular cargos can be well controlled [30–32]. The combination of these features, derived 
from the porous scaffolds and SLB, distinguishes nanoporous silica-based protocells from “hollow” 
liposomes or vesicles and membrane-free nanoparticles or droplets as a promising alternative platform 
for synthetic biology. Furthermore, like a cell, the nanostructured silica particle is optically transparent, 
allowing cutting edge fluorescence imaging techniques, such as fluorescence resonance energy transfer 
(FRET), to be readily applied to study real-time molecular functions within protocells. 
Life 2015, 5 217 
 
 
The protocell fabrication process consists of synthesis of the silica particle core according to a myriad 
of “sol-gel” and self-assembly approaches developed in our laboratory, followed by loading of 
biomolecular cargos and liposome fusion to form a supported lipid bilayer surrounding the core.  
The cores are formed principally by an aerosol-assisted self-assembly process [33], wherein aerosol 
droplets are generated, transferred under laminar flow through drying and heating zones, and collected. 
Starting with an initially homogeneous ethanol-water solution of soluble silica plus amphiphilic surfactants 
or block copolymer templating agents, with initial surfactant concentration c0 less than the critical micelle 
concentration, solvent evaporation drives radially-directed silica surfactant self-assembly into ordered 
periodic mesophases confined to spherical droplets [34]. Solidification of the droplet by rapid heating 
followed by extraction of the surfactant or block copolymer results in a porous silica replica of the 
mesophase characterized by an ordered periodically arranged pores that are uniform in size [33,34]. The 
pore size can be adjusted from 2 to over 20 nm. Particle size is controlled principally by concentration 
of the precursor solution, and is adjusted in order to mimic the dimension of natural cells and enable 
optical microscopy and spectroscopy. 
Membranes are put onto protocells by incubation with liposomes (Figure 1A). Hence any chemical 
composition of membrane that can be formed into liposomes can be used to coat a protocell. In addition, 
proteins and other membrane molecules can be incorporated into the protocell membrane either before or 
after the liposome incubation step. The protocells, which consist essentially of the liposomes supported by 
nanoporous silica scaffolds, are much more robust and long-lived than ordinary liposomes [35]. In our 
view, protocells should be seriously considered as a general alternative to liposomes. 
The newly developed cell/silica composites (CSCs) in our group have much greater fidelity to the 
structure of living cells than completely synthetic nanoporous silica spheres [22]. They utilize 
mammalian cells as the template to fabricate silica replicas capturing the remarkable 3D intra- and 
extracellular features of real cells with stabilized nanomaterials. These replicas are essentially 
indistinguishable from living cells in electron microscopy images. The replicas contain pores and 
cavities of a wide range of sizes in the nanometer range and the surface recapitulates the 3D nature of a 
natural cytoskeleton. They can be loaded with different chemicals and coated with a lipid bilayer, and 
therefore can be utilized as a scaffold for protocells (Figure 1A). 
3. Nanoporous Silica-Based Protocells 
3.1. Reconstitution of Membrane Proteins in the Lipid Bilayer of Protocells 
Compartmentalization is a critical feature of living cell. It is achieved by a membrane that separates 
the interior of the cell from its environment with controlled exchange of ions, nutrition/sugar and 
energy/ATP, small molecules, and macromolecules. The selective exchange (uptake and release) of ions 
and materials across membranes is controlled by membrane proteins with diverse functions, such as 
passive transport, facilitated diffusion and active transport. Therefore, reconstitution of membrane 
proteins in the protocell platform (1) enables the functional study of the protein of interest in a well-defined 
system; (2) builds a biomimetic microreactor for controlled synthesis of inorganic multicomponent 
materials; (3) creates membranes with desired function of material exchange, which is essential for the 
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design of life. Simple compartmentalized modules with partial cellular functions may also give us insight 
into early or minimal life forms. 
Lipid vesicles have been widely used to study membrane proteins. Even though the lipid bilayers in 
the vesicles function as barriers, as mentioned above, they suffer from inherent instability. Supported 
lipid bilayers on planar or particulate solid substrates, such as silicon dioxide/silica, show enhanced 
stability [36–38]. There are several monolayers of water between the silica and the lipid bilayer, allowing 
the free diffusion of incorporated membrane proteins [38,39]. We hypothesize that the non-bulk water 
structure between the bilayer and the support accounts for one of the distinctive properties of bilayers 
on a nanoporous substrate; that is, increased lateral mobility of membrane molecules [40]. 
Several groups have pioneered the functionalization of protocell membranes. Brozik et al. 
characterized in detail the properties of lipid bilayers on an array of nanoporous silica microspheres  
(10–30 µm sphere size, 10–100 nm pore size) [35]. They discovered that the larger sphere size and 
smaller pore size correspond to increased bilayer stability. The light-driven proton pump in Archaea, 
bacteriorhodopsin, was successfully reconstituted in the lipid bilayer of protocells with 70% displaying the 
correct orientation. Functional assay with a loaded pH-sensitive dye confirmed that bacteriorhodopsin 
pumps proton upon photon absorption. They also tested two methods of protein functionalization on 
protocells: (1) proteoliposome deposition on silica surfaces; and (2) protein direct incorporation into 
preformed detergent-saturated supported bilayers. A serotonin receptor, 5HT3R, was purified from 
human embryonic kidney cells and incorporated in the protocells with each method. The second 
approach resulted in 94% correctly oriented 5HT3R vs. 74% with the first method, suggesting that 
interaction with the core of the protocells may help position the membrane proteins in the right 
orientation--another advantage of the protocell platform. One hypothesis for the effect is that the 
adhesion between supported lipid bilayer and nanoporous silica core may prevent large extracellular 
portion of the receptor from crossing the membrane. We anticipate that further improvement of precision 
orientation of membrane proteins may be possible by adjusting charge on the silica core. Serotonin-induced 
calcium release was observed in the protocells, confirming the presence of correctly oriented functional 
5HT3R in protocells. Unfortunately patch clamp experiments were not possible with silica-based 
protocells as the rigid silica support doesn’t allow the formation of gigaseals for single-channel and 
whole-cell patch clamp. 
Another multisubunit transmembrane functional proton pump, cytochrome c oxidase (CytocO) was 
reconstituted on porous silica particles (550 nm sphere size, 3 nm pore size) by Bergstrom and Brzenzinksi 
groups [41]. Their results showed that the protein-lipid ratio was the same in the vesicles and protocells. 
CytocO can be reduced selectively and the amount of reduced CytocO can be measured, providing a 
simple way to determine its orientation. First they used a membrane impermeable reducing agent to 
reduce all CytocO proteins facing outward and then added a permeable reducing agent to reduce those 
facing inside and then calculated the ratio of these two populations. They showed that the orientation of 
CytocO in vesicles is 71% ± 4%, not significantly different from 68% ± 5% in protocells. This result 
strongly suggests that membrane protein orientation is preserved during the fusion of liposomes with the 
protocell core. The formation of a transmembrane electrochemical proton gradient in CytocO-containing 
protocells not only confirmed the activity of the complex but also the integrity of the lipid bilayer for 
being impermeable to protons. Our summary inferences from the above-cited two papers are:  
(1) Orientation of membrane proteins in protocells is preserved during liposome fusion to the core, which 
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may shed some light on the fusion mechanism [41]; (2) The orientation of the proteins in liposomes is 
not completely random (for all three proteins the reported orientation was about 70% in the biologically 
correct direction) [35,41]; (3) If the protein is inserted into the protocell membrane after fusion with the 
silica core, the orientation may be enhanced to have even greater fidelity to the biological 
orientation [35]. 
The Bergstrom group extended their work from proton transport to sodium transport and studied  
two membrane proteins through liposomal fusion of small unilamellar vesicles onto the nanoporous 
silica spheres (6 µm sphere size, 2.6 nm pore size) [42]. The large size of the silica spheres in this study 
allows confocal imaging to assay real-time membrane protein activities of protocells, similar to imaging 
live cells. Using Sodium Green, a sodium-sensitive dye that increases in fluorescence upon interaction 
with sodium, imaging provides spatial and temporal resolution of the sodium concentrations.  
The stability, durability and permeability of supported lipid bilayers with various components were 
tested with dyes, confirming the integrity of membranes. Passive sodium uptake and release along the 
chemical concentration gradient were imaged with the integration of gramicidin A (a univalent cation  
channel-forming peptide) in the protocell membrane. In addition, active transport of sodium by a primary 
sodium ion transporter ATP synthase in the presence of ATP was demonstrated using dye-loaded 
particles imaged using time lapse confocal laser scanning microscopy. Imaging individual protocells 
also showed heterogeneity of the intensity and dynamics of fluorescence inside the core, which may 
result from the heterogeneous concentrations of the bilayer-bound membrane proteins and variations in 
the pore volume and structure of the core. The heterogeneity of liposome-based protocells was discussed 
previously [43]. This level of resolution is not possible with protocells of nanometer size, which cannot be 
imaged individually due to the limit of diffraction. This study also illustrated the advantage of the porous 
silica spheres as support for lipid bilayer compared to solid ones, which are unable to incorporate dyes. 
As ATP is an energy source for many biochemical reactions, ATP permeability of the membrane can 
be controlled by membrane proteins. The pore-forming toxin α-hemolysin has been shown to be 
permeable to ATP in liposomes [44]. Other naturally-occurring membrane proteins which are permeable 
to ATP have not yet been reported in protocells. The voltage-dependent anion channel 1(VDAC1),  
a membrane protein in the outer mitochondrial membrane, has been shown permeable to ATP [45].  
Our group has found that VDAC1 can be successfully incorporated into protocell membranes composed 
of either DOPC, or of soy lecithin (Figure 1B). In detail, purified VDAC1 proteins in micelles [46,47] 
were incubated with small unilamellar vesicles (SUVs) made of either DOPC or soy lecithin first and 
the detergent was subsequently removed to make the VDAC1 proteoliposome. The proteoliposome was 
incubated with nanoporous silica particles to create protocells with VDAC1 incorporated in the 
membrane. The functionality of VDAC1 will be further studied in the protocell platform. 
The above examples have demonstrated the protocell as a versatile platform to reconstitute membrane 
proteins for both functional studies and biomimetic synthesis. Up to now only single species of 
membrane proteins have been studied at one time in protocells even though multiple membrane proteins 
have been reconstituted in liposomes [48]. In the future multiple membrane proteins with related or 
diverse functions will likely be combined together into one protocell, mimicking the diversity and 
complexity of biological membranes in living cells. Additionally for membranes supported on silica cell 
replicas, we expect that, due to the local variation in curvature imposed by the cytoskeleton-like scaffold, 
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lateral forces mimicking those of living systems will be generated leading to new phase behavior and 
life-like complexity. 
 
Figure 1. (A) Fusion of small unilamellar vesicles on nanoporous silica cell replicas and 
other silica particles forms protocells; (B) The sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) showed the VDAC1 protein (arrow) from different samples. 
VDAC1 successfully incorporated into the DOPC or Soy Lecithin-coated protocells (Lane 9 
and 10) while the supernatant of the centrifuged protocells contained no VDAC1 (Lane 7  
and 8). Most VDAC1 proteins precipitated when detergent Lauryldimethylamine-oxide 
(LDAO) was removed from the lipid-detergent-protein mixture (Lane 3 and 4). Original 
SUVs before protein incorporation had no VDAC1 (Lane 5 and 6). 
3.2. Reconstitution of Biochemical Reactions inside Porous Silica Core of Protocells 
We have discussed the reconstitution of biological membranes in protocells. The first step to 
reconstitute the cytosol of living cells is also being pursued. The cytosol of living cells contains thousands 
of soluble proteins, which carry out myriads of biochemical reactions. Liposomes have been used as a 
cytosol mimicking bioreactor for complicated biochemical reactions, such as polymerase chain  
reaction and protein synthesis [9,44]. However, the aqueous interior of liposomes cannot mimic  
the macromolecular crowding in living cells where biochemical reactions happen. Our group has  
pioneered the aerosol-assisted assembly of porous silica with 2D hexagonally ordered cylindrical 
channels/pores [33], which is a rough mimic of cellular cytoskeleton. Equally interestingly, we have 
Life 2015, 5 221 
 
 
recently developed the technology to make silica replicas of mammalian cells that preserve the detailed 
structural features of the living cell, including the crowded and tortuous intracellular pathways for 
diffusion [22]. The porous silica cell replica is a compelling alternative as the cell-templated porosity is 
a closer mimic of cellular cytoskeleton and simulates the effect of in vivo macromolecular crowding. 
Even though few biochemical reactions have so far been reconstituted in the lipid-bilayer-covered porous 
silica, various functional enzymes have been encapsulated inside porous silica, suggesting the 
plausibility of this idea [49]. 
A model system based on the protocell can allow an extracellular signal to be perceived by a 
membrane-bound receptor, which in turn triggers intracellular signaling cascades. This arrangement 
constitutes the core module of how cells respond to environmental signals. The exemplary system is the 
cell’s response to platelet-derived growth factor (PDGF), which regulates cell growth and division. 
PDGFs bind to PDGF receptors on the plasma membrane and induce dimerization of the receptors [50], 
which in turn modulate the activity of downstream effectors, such as tyrosine phosphatases Shp2, an 
important molecule associated with Noonan syndrome, LEOPARD syndrome and Chronic 
Myelomonocytic Leukemia [51–53]. 
Using an Shp2 biosensor based on FRET, we have found that the nature of intramolecular interactions 
between domains within Shp2 upon extracellular stimulation of cells by PDGF is quite different from 
the corresponding interaction in solution as stimulated by PDGFRβ kinase (the putative intracellular 
signaling domain activated by PDGF binding) [54]. The engineered cellular entity with controllable 
environment and compositions based on the protocell allows us to gain insights into the fundamental 
principles governing the molecular regulation under different environments. A FRET biosensor 
containing a full length Shp2 flanked by an enhanced cyan fluorescent protein (ECFP) and a yellow 
fluorescent protein variant (YPet) was constructed [54]. The purified Shp2 biosensor can be 
phosphorylated by PDGFRβ kinase in vitro and undergo subsequent conformational change, causing a 
corresponding FRET increase (Figure 2A). We utilize this established biochemical reaction between 
Shp2 biosensor and PDGFRβ kinase to study its reconstitution in protocells, which can be monitor by 
FRET imaging. 
Our preliminary study showed the successful loading of fluorescent Shp2 biosensor into the silica cell 
replica (Figure 2B). A lipid bilayer membrane can be assembled on the surface of these replicas from 
liposome fusion (Figure 1A) to create the protocell architecture that mimics both the tortuosity of the 
internal milieu and also the nanoporous support of the cell membrane. First, silica cell replicas were 
incubated with the FRET-based Shp2 biosensor and PDGFRβ kinase for protein loading into the pores. 
Upon the ATP addition, a clear FRET change can be observed in silica cell replicas as ATP can initiate 
the reaction between the Shp2 biosensor and PDGFRβ kinase (Figure 2A,C), indicating the reconstitution 
of biochemical reactions inside the porous structure. Notably, there was no lipid bilayer in these silica 
cell replicas, permitting ATP to diffuse inside freely. In the future, we plan to fuse an ATP-permeable 
lipid bilayer on the silica cell replicas, incorporating either α-hemolysin or VDAC1, and beyond that a 
lipid bilayer that will comprehensively mimic the PDGF signaling pathway. 
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Figure 2. (A) The design of the FRET-based Shp2 biosensor; (B) The protocells visualized 
with coated DOPC membranes with 1% Texas Red- DHPE and loaded fluorescent Shp2 
biosensor inside the silica cell replicas; (C) In the presence of loaded PDGFR kinase, the 
FRET of the Shp2 biosensor inside silica cells increased upon ATP addition. 
3.3. Protocells as Nanocarriers for Targeted Drug Delivery 
We have discussed mostly protocells of micrometer size for various in vitro reconstitution 
experiments in the area of basic research. Meanwhile, nanomedicine as a new type of theranostics is 
revolutionizing our pharmaceutical industry with superior properties compared to conventional free drug 
treatment [55]. Liposomes as a type of nanocarrier, have been extensively studied and approved for 
clinical uses [56]. Silica-based protocells of nanometer size have the potential be designed for targeted 
drug delivery as a new type of nanomedicine [57]. Our group has also pioneered research in this area. 
We have designed and optimized protocell-based multicomponent cargo delivery, specific to liver 
cancer cells, combining features of nanoporous silica particles and liposomes [4] (Figure 3). The lipid 
bilayer was modified with a targeting peptide, a fusogenic peptide, and PEG, to achieve targeting 
specificity, endosomal escape and extended circulation time, respectively. The nanoporous silica cores 
(120 nm sphere size, 2.5 nm pore size) were shown to accommodate various therapeutic and diagnostic 
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cargos, such as quantum dots for imaging, chemotherapeutic drugs and nucleic acid. Comparative studies 
with liposomes of identical bilayer compositions and size were done to demonstrate the advantage of the 
protocells with respect to features important for nanomedicine: enhanced capacity, selectivity and 
stability. The improved capacity is a result of the high surface area of the nanoporous silica core while 
the lipid-silica interaction increases the stability to reduce cargo leakage in vivo. In addition, the 
nanoporous support also increased lateral mobility of molecules such as targeting peptides in the lipid 
bilayer (as compared to both liposomes or lipid bilayer on non-porous solid support), which contribute 
to the selectivity and efficiency of the peptide. Together, the synergistic combination of two established 
and well-studied materials allows high delivery efficiency and improved targeting specificity, which are 
essential features for effective nanomedicine with maximal target effects and minimal off-target effects. 
In particular, protocells were found to bind to hepatocellular carcinoma cells (HCCs) with low 
targeting-peptide densities while liposomes failed to do so, because the enhanced fluidity of lipid bilayers 
on the protocell facilitated multivalent peptide binding to the cell surface [58]. This unique advantage of 
the protocells is critical to enhance specific affinity of the targeting peptide and guide receptor-mediated 
endocytosis of protocells. We found selective internalization of protocells with low density peptides by 
HCCs, but not by normal hepatocytes. After endocytosis, the fusogenic peptide on the protocells 
promotes endosomal escape of protocells and therefore prevents degradation of cargos within the 
endolysomes. With the successful engineering of the protocells for targeted delivery, Ashley et al. 
delivered high pay loads of various cytotoxic agents to HCCs to test the effectiveness of protocells. For 
doxorubicin, protocells were reported to have a 1000 times higher capacity (with 90% release) than 
similar sized liposomes. By contrast, the leakage of liposomes was 90% within 72 h, while protocells 
could last weeks with less than 20% leakage. In addition, protocells displayed a prolonged release of 
doxorubicin in endosomal-mimicking buffer. The end results are the effective killing of HCCs by 
protocells (90%) while more than 90% normal hepatocytes stay alive. This differential effect is only 
seen with treatment of protocells but not liposomes. Our silica-based protocells show great promise to 
kill cancer cells in vitro and efforts are being made for their in vivo testing. 
As a new therapeutic agent, small interfering RNA (siRNA) has many advantages over conventional 
small molecule-based therapy [59]. RNA therapy is potentially exquisitely specific and powerful. Design 
of siRNA is relatively easy in the genomic age as the sequences of targeted genes and regulatory 
elements are available. The problem is delivery, because bare RNA is very fragile and cells have 
enzymes to degrade foreign RNA. Therefore, the key to RNA therapy is protection and targeted delivery. 
Our group followed up the work on nanoscale protocells and tailored them for siRNA delivery [60]. The 
key modifications of the protocells for siRNA loading include changing the surface charge of the silica 
core to positive and increasing the pore size to accommodate siRNA. Through the reaction of silica with 
an amine-containing silane, the surface of the protocells becomes positive and therefore has strong 
electrostatic interaction with negatively charged siRNA molecules, which increases the loading capacity 
more than 10 fold. Using positively charged liposomes for protocell fusion can also enhance the loading 
of siRNA into unmodified negatively charged silica cores, but this design has higher cytotoxicity than 
zwitterionic lipids on positive cores. The silica cores (165 nm) in these protocells have a multimodal 
pore morphology composed of large (23–30 nm), surface-accessible pores interconnected by 3–13 nm 
ones so that siRNA of 5–6 nm can be loaded. The commercially available cationic lipid nanoparticles 
were used as the control for comparison. Our modified protocell has higher siRNA loading, enhanced 
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stability as well as slower release, making it a superior nanocarrier for siRNA delivery. With established 
targeting and fusogenic peptides, siRNAs targeting the cyclin superfamily were successfully delivered 
to HCCs. They had a dramatic effect, inducing cell growth arrest and apoptosis, confirming the targeted 
delivery by protocells. 
 
Figure 3. The cartoon depicts the nanoporous silica-based protocell for drug delivery. 
Our vision is that basic research on membrane proteins and cytosol reconstitution in protocells of 
micrometer size will be translated to protocells of nanometer size, which could potentially extend the 
range of applications to targeted narrow spectrum antimicrobial therapy. 
4. Conclusions and Future Prospects 
By integrating nanoscience, molecular biosensors and imaging, and biochemistry in the context of 
systems biology and synthetic biology, we are establishing a protocell platform to reconstitute and model 
cellular complexity. This will be an important component of a general and systematic approach to 
understand the design principles of molecular networks in a cellular environment. Protocell-based 
research will have fundamental implications for understanding information flow in biomolecular 
networks and directed self-assembly at the nanoscale. The protocell can also serve as a platform for 
investigating how the properties of membranes depend on their physical environment, and how confined 
geometries influence biochemical reactions. 
The nanoporous silica-based protocell model is part of the foundation for a completely bottom-up 
synthetic biology, in which all parts of a biomimetic cell can be quantitatively characterized and therefore 
understood at a level that is impossible in more genomically complete constructs. This work should be 
regarded as complementary and synergistic to both other synthetic biology work, that begins with a  
living cell [2,61], or other protocell work, that begins with the concept of a self-replicating chemical  
network [7,61–63]. This is just the beginning of the protocell era. The data generated with the protocells 
can be readily adapted for computational modeling, which should bridge the gap between in vitro and in 
cell results. Although current progress only demonstrates relatively simple cellular functions, we can 
readily increase complexity of the system by adding more modules and/or feedback modules.  
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Patch clamp experiments on ion channels have not been possible with silica-based protocells as the 
rigid silica support doesn’t allow the formation of gigaseals for single-channel and whole-cell patch 
clamp [35]. Conceivably we could construct protocells with a softer core (e.g., organic polymers) or 
dissolvable core that would help to direct the formation of a cytoskeleton and assemble molecular 
components and then be removed to enable cell-like mechanical properties. This is a step towards 
ultimately replacing the rigid silica core with a more biomimetic actin cytoskeleton, which would open 
the possibilities of motility and replication—beyond the scope of the current functional protocells but 
indicative of future possibilities.  
The bottom-up cell, especially in the early stages of implementing the approach, is very 
oversimplified compared to any living cell. Thus current work of the assembly of membrane and 
intracellular components is only the first step, leading to more complexity as more components are 
added. Within such protocells we could incorporate the replication machinery to study the origin of life. 
Ultimately we can incorporate the “genome” into the protocells and start to engineer the supporting 
structure step by step to replicate any desired function of a living cell. Ultimately the bottom-up and  
top-down approaches will converge on a minimal living cell, whose operation will be completely 
understood, because it will have been created de novo. Our protocell system has the potential to serve as 
a significant tool to advance our understanding of the chemistry of life. 
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